ENDRA Life Sciences (NDRA) Receivables (2017 - 2018)
ENDRA Life Sciences' (NDRA) quarterly Receivables came in at $12275.0 in Q3 2018, up 4.29% quarter-over-quarter from $11770.0 in Q2 2018.
Powered by 
Analysis
ENDRA Life Sciences (NDRA) Receivables (2017 - 2018) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Receivables for 2 consecutive years, with $12275.0 the latest figure, recorded in Q3 2018.
- On a quarterly basis, Receivables changed N/A year-over-year to $12275.0 in Q3 2018; TTM through Sep 2018 was $12275.0, a N/A change from a year earlier, with the FY2017 full-year figure at $6850.0, changed N/A from the prior year.
- Receivables was $12275.0 for Q3 2018 at ENDRA Life Sciences, up from $11770.0 in the prior quarter.
- Over five years, Receivables peaked at $12275.0 in Q3 2018 and troughed at $6850.0 in Q4 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn | 4.66 Bn |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn | 352.89 Mn |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn | 43.27 Mn |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn | 146.80 Mn |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn | 34.55 Mn |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn | 18.19 Mn |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn | 144.70 Mn |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - | 3.66 Mn |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - | 470.30 Mn |
| 10 | ENDRA Life Sciences | 8.25 Mn | 2.71 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2018 | 12,275.00 |
| Jun 30, 2018 | 11,770.00 |
| Mar 31, 2018 | 11,770.00 |
| Dec 31, 2017 | 6,850.00 |